156 related articles for article (PubMed ID: 17384671)
1. Optimal primer design using the novel primer design program: MSPprimer provides accurate methylation analysis of the ATM promoter.
Brandes JC; Carraway H; Herman JG
Oncogene; 2007 Sep; 26(42):6229-37. PubMed ID: 17384671
[TBL] [Abstract][Full Text] [Related]
2. The molecular causes of low ATM protein expression in breast carcinoma; promoter methylation and levels of the catalytic subunit of DNA-dependent protein kinase.
Treilleux I; Chapot B; Goddard S; Pisani P; Angèle S; Hall J
Histopathology; 2007 Jul; 51(1):63-9. PubMed ID: 17593081
[TBL] [Abstract][Full Text] [Related]
3. Critical role of deltaDNMT3B4/2 in regulating RASSF1A promoter-specific DNA methylation in non-small cell lung cancer.
Wang SH; Liu NH; Wang J; Bai H; Mao L
Chin Med J (Engl); 2008 Sep; 121(17):1712-21. PubMed ID: 19024105
[TBL] [Abstract][Full Text] [Related]
4. Contribution of mutations in ATM to breast cancer development in the Czech population.
Soukupova J; Dundr P; Kleibl Z; Pohlreich P
Oncol Rep; 2008 Jun; 19(6):1505-10. PubMed ID: 18497957
[TBL] [Abstract][Full Text] [Related]
5. Down-regulation of ATM protein in HRS cells of nodular sclerosis Hodgkin's lymphoma in children occurs in the absence of ATM gene inactivation.
Bose S; Starczynski J; Chukwuma M; Baumforth K; Wei W; Morgan S; Byrd P; Ying J; Grundy R; Mann JR; Tao Q; Taylor AM; Murray PG; Stankovic T
J Pathol; 2007 Nov; 213(3):329-36. PubMed ID: 17876757
[TBL] [Abstract][Full Text] [Related]
6. Relevance of MSP assay for the detection of MGMT promoter hypermethylation in glioblastomas.
Yachi K; Watanabe T; Ohta T; Fukushima T; Yoshino A; Ogino A; Katayama Y; Nagase H
Int J Oncol; 2008 Sep; 33(3):469-75. PubMed ID: 18695875
[TBL] [Abstract][Full Text] [Related]
7. Methylation-specific PCR.
Licchesi JD; Herman JG
Methods Mol Biol; 2009; 507():305-23. PubMed ID: 18987823
[TBL] [Abstract][Full Text] [Related]
8. The ATM gene is a target for epigenetic silencing in locally advanced breast cancer.
Vo QN; Kim WJ; Cvitanovic L; Boudreau DA; Ginzinger DG; Brown KD
Oncogene; 2004 Dec; 23(58):9432-7. PubMed ID: 15516988
[TBL] [Abstract][Full Text] [Related]
9. ATM promoter analysis in childhood lymphoid malignancies: a brief communication.
Gumy-Pause F; Wacker P; Maillet P; Betts DR; Sappino AP
Leuk Res; 2006 Mar; 30(3):335-7. PubMed ID: 16125772
[TBL] [Abstract][Full Text] [Related]
10. methBLAST and methPrimerDB: web-tools for PCR based methylation analysis.
Pattyn F; Hoebeeck J; Robbrecht P; Michels E; De Paepe A; Bottu G; Coornaert D; Herzog R; Speleman F; Vandesompele J
BMC Bioinformatics; 2006 Nov; 7():496. PubMed ID: 17094804
[TBL] [Abstract][Full Text] [Related]
11. Promoter hypermethylation profile of RASSF1A, FHIT, and sFRP1 in intracranial primitive neuroectodermal tumors.
Chang Q; Pang JC; Li KK; Poon WS; Zhou L; Ng HK
Hum Pathol; 2005 Dec; 36(12):1265-72. PubMed ID: 16311119
[TBL] [Abstract][Full Text] [Related]
12. Aberrant methylation of the ATM promoter correlates with increased radiosensitivity in a human colorectal tumor cell line.
Kim WJ; Vo QN; Shrivastav M; Lataxes TA; Brown KD
Oncogene; 2002 May; 21(24):3864-71. PubMed ID: 12032824
[TBL] [Abstract][Full Text] [Related]
13. PRIMEGENS-v2: genome-wide primer design for analyzing DNA methylation patterns of CpG islands.
Srivastava GP; Guo J; Shi H; Xu D
Bioinformatics; 2008 Sep; 24(17):1837-42. PubMed ID: 18579568
[TBL] [Abstract][Full Text] [Related]
14. Detection of RASSF1A aberrant promoter hypermethylation in sputum from chronic smokers and ductal carcinoma in situ from breast cancer patients.
Honorio S; Agathanggelou A; Schuermann M; Pankow W; Viacava P; Maher ER; Latif F
Oncogene; 2003 Jan; 22(1):147-50. PubMed ID: 12527916
[TBL] [Abstract][Full Text] [Related]
15. Methylation of p16 and Ras association domain family protein 1a during colorectal malignant transformation.
Umetani N; de Maat MF; Sunami E; Hiramatsu S; Martinez S; Hoon DS
Mol Cancer Res; 2006 May; 4(5):303-9. PubMed ID: 16687485
[TBL] [Abstract][Full Text] [Related]
16. MSP-HTPrimer: a high-throughput primer design tool to improve assay design for DNA methylation analysis in epigenetics.
Pandey RV; Pulverer W; Kallmeyer R; Beikircher G; Pabinger S; Kriegner A; Weinhäusel A
Clin Epigenetics; 2016; 8():101. PubMed ID: 27688817
[TBL] [Abstract][Full Text] [Related]
17. Characterization of the porcine ATM gene: towards the generation of a novel non-murine animal model for Ataxia-Telangiectasia.
Rogatcheva MB; Fritz KL; Rund LA; Pollock CB; Beever JE; Counter CM; Schook LB
Gene; 2007 Dec; 405(1-2):27-35. PubMed ID: 17933474
[TBL] [Abstract][Full Text] [Related]
18. Fragile genes as biomarkers: epigenetic control of WWOX and FHIT in lung, breast and bladder cancer.
Iliopoulos D; Guler G; Han SY; Johnston D; Druck T; McCorkell KA; Palazzo J; McCue PA; Baffa R; Huebner K
Oncogene; 2005 Feb; 24(9):1625-33. PubMed ID: 15674328
[TBL] [Abstract][Full Text] [Related]
19. BiSearch: primer-design and search tool for PCR on bisulfite-treated genomes.
Tusnády GE; Simon I; Váradi A; Arányi T
Nucleic Acids Res; 2005 Jan; 33(1):e9. PubMed ID: 15653630
[TBL] [Abstract][Full Text] [Related]
20. Promoter methylation patterns of ATM, ATR, BRCA1, BRCA2 and p53 as putative cancer risk modifiers in Jewish BRCA1/BRCA2 mutation carriers.
Kontorovich T; Cohen Y; Nir U; Friedman E
Breast Cancer Res Treat; 2009 Jul; 116(1):195-200. PubMed ID: 18642075
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
